19 Jul 2018 --- A recent review notes that only two percent of trials in the widening research space around probiotics, prebiotics and synbiotics publish full safety data, highlighting the need for more comprehensive adverse risk reporting. Due to this, researchers warn that they cannot broadly conclude that these interventions are safe. However, industry players have refuted the “allegations” that the ingredients should be seen as “unsafe” due to the lack of safety data published.